- Home
- CENT vs NNNN Comparison
CENT vs NNNN Comparison
Compare CENT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENT
- NNNN
- Stock Information
- Founded
- CENT 1955
- NNNN 2021
- Country
- CENT United States
- NNNN Germany
- Employees
- CENT N/A
- NNNN N/A
- Industry
- CENT Consumer Specialties
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CENT Consumer Discretionary
- NNNN Health Care
- Exchange
- CENT Nasdaq
- NNNN Nasdaq
- Market Cap
- CENT 2.2B
- NNNN 2.2B
- IPO Year
- CENT N/A
- NNNN 2025
- Fundamental
- Price
- CENT $37.63
- NNNN $47.85
- Analyst Decision
- CENT Strong Buy
- NNNN
- Analyst Count
- CENT 2
- NNNN 0
- Target Price
- CENT $42.50
- NNNN N/A
- AVG Volume (30 Days)
- CENT 64.5K
- NNNN 75.7K
- Earning Date
- CENT 08-06-2025
- NNNN 01-01-0001
- Dividend Yield
- CENT N/A
- NNNN N/A
- EPS Growth
- CENT N/A
- NNNN N/A
- EPS
- CENT 2.14
- NNNN 0.06
- Revenue
- CENT $3,120,375,000.00
- NNNN $8,185,146.00
- Revenue This Year
- CENT N/A
- NNNN N/A
- Revenue Next Year
- CENT $0.16
- NNNN N/A
- P/E Ratio
- CENT $17.58
- NNNN $878.62
- Revenue Growth
- CENT N/A
- NNNN 21.95
- 52 Week Low
- CENT $31.97
- NNNN $5.18
- 52 Week High
- CENT $43.88
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- CENT 55.85
- NNNN N/A
- Support Level
- CENT $36.42
- NNNN N/A
- Resistance Level
- CENT $36.24
- NNNN N/A
- Average True Range (ATR)
- CENT 0.84
- NNNN 0.00
- MACD
- CENT 0.26
- NNNN 0.00
- Stochastic Oscillator
- CENT 78.99
- NNNN 0.00
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.